Monkeypox Market Growth 2024-2031: Key Players, Regional Insights, and Future Opportunities in Vaccines & Drugs

Global Monkeypox Market reached US$ 93.17 million in 2023 and is expected to reach US$ 264 million by 2031, growing at a CAGR of 10.16% during the forecast period 2024-2031.

The Monkeypox Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

📌 Access valuable insights with our sample report - (Please enter your Corporate Email ID to get priority access):- https://datamintelligence.com/download-sample/monkeypox-market?rk

☛ Monkeypox Market Forces Driving Future Growth

The rising incidence of monkeypox and increasing outbreak preparedness are driving the global market forward. Growing numbers of confirmed cases, along with heightened public health vigilance, have fueled demand for vaccines, treatments, and diagnostics. Governments and healthcare systems worldwide are prioritizing resources to contain outbreaks and prevent future surges.

At the same time, there is a surge in demand for diagnostics and early detection tools. Rapid and accurate testing, particularly PCR and serological methods, has become a cornerstone of monkeypox management. The need for early intervention and outbreak control is accelerating investment in diagnostic technologies, supporting the market's expansion.

Another major driver is vaccine and therapeutic development. Innovative antiviral drugs such as Tecovirimat and Brincidofovir, as well as immunoglobulin therapies, are showing promise. The development of both live and inactivated vaccines is central to strengthening public health defense systems, opening opportunities for biopharmaceutical companies.

Government funding and regulatory approvals are also critical to market growth. Proactive financing of infectious disease research, emergency use authorizations, and expanded indications for vaccines like ACAM2000 for mpox prevention are enabling faster access to essential solutions. These measures ensure that therapies and vaccines reach affected populations more quickly.

☛ Monkeypox Industry News:

High Demand for Bavarian Nordic's Jynneos Vaccine
Following an mpox public health emergency declaration by WHO, Bavarian Nordic's Jynneos vaccine surged in demand. The company pledged 10 million doses for African nations by the end of 2025. Their stock price rose significantly amid global ordering activity.

Major players like Emergent BioSolutions, Tonix Pharmaceuticals, Moderna, and BioNTech are also actively developing or trialing mpox vaccines.

☛ Monkeypox Market: Industry Giants and Emerging Leaders:

Bavarian Nordic A/S, Emergent BioSolutions Inc., SIGA Technologies, Inc., BASF Corporation, Wellona Pharma, Zuche Pharmaceuticals Private Limited, Sambria Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Pfizer Inc. and Teva Pharmaceuticals USA, Inc.

Research Methodology

Our research methodology employs a dual approach, combining qualitative insights with rigorous quantitative analysis to provide comprehensive and reliable market intelligence. The process begins with thorough secondary research, drawing from trusted industry publications, proprietary databases, and credible market sources. This is further enhanced by focused primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/monkeypox-market

☛ Segment Covered in the Monkeypox Market:

By Treatment Type: Vaccine Type, Drug Type.

By Route of Administration: Oral, Topical, Parenteral.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others.

☛ This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Top-down and bottom-up approach for regional analysis

📌 Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=monkeypox-market

☛ Regional Analysis for Monkeypox Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

☛ Frequently asked questions:

➠ What is the global sales, production, consumption, import, and export value of the Monkeypox Market?
➠ Who are the key global manufacturers, and what is their operational performance?
➠ What are the major opportunities and threats in the global Monkeypox Market?
➠ Which product types or end-users show the most growth potential and market share?
➠ What challenges and constraints are impacting the Monkeypox Market?
➠ What sales, marketing, and distribution channels are used globally?

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.